Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00614029 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System
A Phase 1 study, sponsored by Zogenix.
- Completed
- Registry status
- Phase 1
- Development phase
- 54
- Enrollment target
NCT00614029 is a Phase 1 study that has completed, run by Zogenix. The registered enrollment target is 54 participants.
The verdict
NCT00614029, a Phase 1 study, has completed, sponsored by Zogenix.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 54 participants
- Enrollment target
Study Summary
A study to evaluate the pharmacokinetics and bioequivalence of sumatriptan delivered by the Intraject system.
Interventions
- DEVICE Sumatriptan (via Intraject System)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2006-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00614029
The ClinicalTrials.gov registry entry for NCT00614029 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zogenix, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sumatriptan (via Intraject System) is the first listed.
NCT00614029 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00614029 about?
NCT00614029 is a clinical study titled "A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System". A study to evaluate the pharmacokinetics and bioequivalence of sumatriptan delivered by the Intraject system.
What is the current status of trial NCT00614029?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 54 participants. The study started on 2006-12.
What interventions are being tested in trial NCT00614029?
The interventions under investigation include: Sumatriptan (via Intraject System) (DEVICE).
Who is sponsoring clinical trial NCT00614029?
This trial is sponsored by Zogenix, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.